$PCRX Headlines It’s crucial to watch growth stocks

New Post Public Reply Private Reply Replies (0) Message Board

Jan 17, 2015 at 11:13 AM

$PCRX Headlines

It’s crucial to watch growth stocks right now 2:06 p.m. Sept. 25, 2014 - The Trading Deck
More reasons to like the Nasdaq in September 2:14 p.m. Sept. 4, 2014 - The Trading Deck
There’s good news for speculative growth traders 1:40 p.m. Sept. 2, 2014 - The Trading Deck
Trade what you see, not what you believe 1:49 p.m. Aug. 29, 2014 - The Trading Deck
Good times for stocks lie ahead 12:47 p.m. Aug. 28, 2014 - The Trading Deck
When will institutions get off the sidelines? 12:43 p.m. Aug. 12, 2014 - The Trading Deck
Nasdaq Composite teeters on major support 9:56 a.m. Aug. 6, 2014 - Michael Ashbaugh
How to know if the next rally is real or bogus 2:06 p.m. Aug. 5, 2014 - The Trading Deck
Nasdaq needs to turn up the volume 10:59 a.m. July 17, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Nasdaq rattles cage on major resistance 9:31 a.m. June 5, 2014 - Michael Ashbaugh
Cyclical stocks test a growth speculator's mettle 1:00 p.m. May 13, 2014 - The Trading Deck
Two names for a two-way stock market 1:42 p.m. May 8, 2014 - The Trading Deck
AIG shares slip, Athenahealth sinks after hours 5:29 p.m. May 5, 2014 - Wallace Witkowski
Einhorn, Gundlach, Ackman, Jones unveil their best longs and shorts at Ira Sohn 5:13 p.m. May 5, 2014 - blogs.marketwatch.com
Scouring the moonscape for leading stocks 2:02 p.m. April 22, 2014 - The Trading Deck
S&P 500 rattles the cage on the 1,800 mark 12:03 p.m. Nov. 18, 2013 - Michael Ashbaugh
The Four Horsemen send a message 12:47 p.m. Nov. 13, 2013 - The Trading Deck
Ignore your feelings, obey the market 12:15 p.m. July 23, 2013 - The Trading Deck
Glamour stocks continue to pave the way 11:34 a.m. July 18, 2013 - The Trading Deck

Hottest Healthcare Stocks Now – NKTR ALXN PCRX AMGN 1:00 p.m. Jan. 16, 2015 - InvestorPlace.com
Pacira Pharmaceuticals, Inc. (PCRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 16, 2015 - Zacks.com
Biggest Movers in Healthcare Stocks Now – LH GSK PCRX ACHN 12:30 p.m. Jan. 15, 2015 - InvestorPlace.com
Update: Pacira's Q4 Revenue Expectations 8:57 a.m. Jan. 10, 2015 - Seeking Alpha
Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog 4:20 p.m. Jan. 9, 2015 - Zacks.com
3 Incredible Growth Stocks to Watch in 2015 - Analyst Blog 9:45 a.m. Jan. 6, 2015 - Zacks.com
New Biotech ETF From ALPS 7:05 a.m. Jan. 2, 2015 - Benzinga.com
New Biotech ETF From ALPS 7:05 a.m. Jan. 2, 2015 - Benzinga.com
Pacira Pharma Reports Changes to EXPAREL Label, Indication Not Affected 7:33 a.m. Dec. 12, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – MYGN PCRX MDCO WCG 6:15 a.m. Dec. 3, 2014 - InvestorPlace.com
PCRX: Insiders Vs. Shorts 2:20 p.m. Dec. 2, 2014 - TheStreet.com
Pacira: Should You Buy The Dip? 10:16 a.m. Nov. 6, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – WCG PDLI BAX PCRX 6:30 a.m. Nov. 5, 2014 - InvestorPlace.com
Pacira Pharmaceuticals' (PCRX) CEO Dave Stack on Q3 2014 Results - Earnings Call Transcript 1:47 p.m. Nov. 2, 2014 - Seeking Alpha
Pacira Down on Wider than Expected Q3 Loss, Sales Miss - Analyst Blog 1:00 p.m. Oct. 31, 2014 - Zacks.com
Today's Dead Cat Bounce Stock: Pacira Pharmaceuticals (PCRX) 9:50 a.m. Oct. 31, 2014 - TheStreet.com
10-Q: PACIRA PHARMACEUTICALS, INC. 3:42 p.m. Oct. 30, 2014 - Edgar Online - (EDG = 10Q, 10K)
Today's Weak On High Volume Stock: Pacira Pharmaceuticals (PCRX) 10:02 a.m. Oct. 30, 2014 - TheStreet.com
Pacira Pharmaceuticals (PCRX) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Oct. 30, 2014 - Seeking Alpha
New Study Correlates Use Of EXPAREL For Postsurgical Pain Management With Significant Reductions In Opioid Related Adverse Events 3:13 p.m. Oct. 27, 2014 - benzinga.com

Pacira Pharmaceuticals, Inc. to Host Analyst & Investor Day on Jan. 22 in New York 4:30 p.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Aratana Therapeutics Initiates Pivotal Study for AT-003 4:28 p.m. Dec. 16, 2014 - PR Newswire - PRF
Pacira Pharmaceuticals Inc. Announces Changes to EXPAREL® Label 8:30 a.m. Dec. 12, 2014 - BusinessWire - BZX
PCRX DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 2, 2014 -- PCRX 11:17 a.m. Dec. 1, 2014 - PR Newswire - PRF
Pacira Pharmaceuticals, Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference 6:30 a.m. Nov. 25, 2014 - BusinessWire - BZX
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 2, 2014 -- PCRX 3:20 p.m. Nov. 24, 2014 - GlobeNewswire
EQUITY ALERT: Rosen Law Firm Reminds Pacira Pharmaceuticals, Inc. Investors of Important December 2, 2014 Deadline in Class Action -- PCRX 6:57 p.m. Nov. 21, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Pacira Pharmaceuticals, Inc. To Contact Brower Piven Before The December 2, 2014 Lead Plaintiff Deadline In Class Action Lawsuit 9:46 p.m. Nov. 19, 2014 - BusinessWire - BZX
Pacira Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors 11:25 a.m. Nov. 18, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 2, 2014 7:06 p.m. Nov. 17, 2014 - BusinessWire - BZX
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Pacira Pharmaceuticals, Inc. Of Upcoming Deadline 6:23 p.m. Nov. 17, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Pacira Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PCRX 5:00 a.m. Nov. 17, 2014 - GlobeNewswire
Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2014 Global London Healthcare Conference 6:30 a.m. Nov. 11, 2014 - BusinessWire - BZX
Pacira Pharmaceuticals Inc. Announces New Data on the Use of EXPAREL to Treat Postsurgical Pain Following Total Knee Arthroplasty 4:00 p.m. Nov. 6, 2014 - BusinessWire - BZX
Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical 9:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Pacira Pharmaceuticals, Inc. and Certain Officers - PCRX 3:07 p.m. Oct. 31, 2014 - PR Newswire - PRF
Pacira Pharmaceuticals, Inc. Reports Third Quarter EXPAREL Revenue of $50.2 Million and Third Quarter 2014 Results 6:30 a.m. Oct. 30, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Pacira Pharmaceuticals, Inc. to Contact Brower Piven Before the December 2, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- PCRX 1:20 p.m. Oct. 29, 2014 - GlobeNewswire
EQUITY ALERT: Rosen Law Firm Reminds Pacira Pharmaceuticals, Inc. Investors of Important Class Action Deadline -- PCRX 2:48 p.m. Oct. 22, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...